Teva Pharmaceutical Industries Limited

TEVA·NYSE·Healthcare
Compare
41.17+0.07 (+0.17%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours41.15−0.02 (−0.06%)Oct 12, 7:21 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close41.10
Open41.29
Day range40.6041.49
52-week range18.8342.02
Off day high−0.77%
Off 52-week high−2.02%
Volume7.18M
Avg. volume (3M)5.48M
Market cap48.02B
EPS (TTM)0.6000
Forward P/E13.36
P/E ratio (TTM)68.62
Dividend yield—
Beta (5Y)0.82
Shares outstanding1.17B
Short interest2.57% of float
Earnings dateNov 3, 2026
Analyst target46.91
Profit margin4.08%

Against its peers

Compare in full ›
TEVA TAK VTRS UTHR HLN RDY
Market cap 48.02B 59.67B 20.15B 23.59B 41.78B 10.68B
P/E (TTM) 68.6 — — 19.7 19.4 29.1
Forward P/E 13.4 35.2 6.6 16.3 15.4 20.0
Price/book 6.2 1.2 1.4 3.7 1.9 16.1
Dividend yield — 3.29% 2.72% — 2.12% 0.67%
1-year change +104.72% +36.52% +78.90% +24.79% +2.64% −13.09%
Today +0.17% −0.27% −0.57% +0.17% +1.93% +2.72%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All TEVA news ›
@gurufocus·

Teva Pharmaceutical Industries Ltd (MEX:TEVA1N) Dividend

MEX:TEVA1N Dividend: Does Teva Pharmaceutical Industries Ltd Pay a Dividend? GuruFocus Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Ltd (MEX:TEVA1N) Dividend Teva Pharmaceutical Industries Ltd (MEX:TEVA1N) does not…

Israel National News·Positive

FDA approves Teva’s once-monthly schizophrenia treatment

Israeli pharmaceutical giant Teva announced Friday that the US Food and Drug Administration (FDA) has approved WELTRUZA, a new once-monthly injectable treatment for adults with schizophrenia. The approval marks a significant milestone for…

From articles in the 4Search news index.

In the news

29mentions in 30 days
10with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 29 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.